GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Statera Biopharma STAB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Statera Biopharma

Our reporting

We have not reported on Statera Biopharma yet.

Past results

Reported against what analysts expected

14 Nov 202215 Nov 202116 Aug 202114 May 202122 Mar 202116 Nov 2020
Earnings per share-0.07-0.47-0.26-0.21-0.16-0.22
Forecast1.27—————
Revenue$670,473$236,519——−$63,255—
Forecast$670,473—————

Key events

  1. 28 Jul 20211-to-1 reverse split
  2. 28 Jan 201520-to-1 reverse split
  3. 21 Jul 2006Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.